Search results for: 'china cell and gene therapy industry development waste ppe'
- Did you mean
- china cell ad g01e therapy industry development waste ppe
- china cell ad gene therapy industry development waste ppe
- Related search terms
- Industry Report on high Value Specialty Steel, Super alloys and titanium Alloy Products Market in India
- Industry Convergence to Transform the Global Plastics and Composites Market, Outlook 2021
- ppe AND gloves
- industry conferenc impacting the global compressor market 2025
- industry convergence impacting the global compressor market 2024
-
11 Nov 2021  |  North America  |  Frost Radar
Frost Radar™: Global Negative Pressure Wound Therapy Technology Devices, 2021
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Wounds, especially chronic wounds, are associated with clinical, social, and economic challenges. Wounds resulting from diabetes, injuries, and surgeries affect a significant population globally. According to an economic evaluation study on Medicare beneficiaries, 8.2 million people in the United States have at least one type of chronic wound. Amon...
$4,950.00 -
29 Apr 2020  |  Global  |  Technology Research
Technology Breakthroughs Driving Allergy & Infectious Disease Therapy
Forthcoming and Available Therapies for Allergy, Infectious Diseases and COVID-19
The current research study discusses the available countermeasures and forthcoming allergic and infectious diseases. The most common allergic diseases such as allergic rhinitis, also know as Hay fever or seasonal allergies; sinusitis; asthma and chronic obstructive pulmonary disease (COPD); atopic dermatitis (or eczema); urticaria (or hives) and mo...
$4,950.00 -
22 Aug 2017  |  North America  |  Market Research
Developments in Image-Guided Therapy, Forecast to 2020
A Prime Area for Multi-Modality Convergence Forming the Next Growth Segment in Medical Imaging
Medical imaging and informatics research service from the Transformational Health practice highlights the evolving trends and innovations in Image-Guided Therapy (IGT). As the fields of interventional imaging, minimally-invasive interventions, and image-guided surgery (IGS) continue to mature, the next step forward in the development of advanced tr...
$3,000.00 -
09 Apr 2015  |  South Asia, Middle East & North Africa  |  Market Research
Global Haemophilia Therapeutics Market
Increased use of recombinant and prophylaxis therapies drives growth
This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...
$3,950.00 -
29 Jun 2023  |  Global  |  Technology Research
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics
Disruptive Technology Advances in SynBio Foster a Thriving Stakeholder Ecosystem and Accelerate Biopharma Developments
The SynBio field has evolved well over the past two decades, with significant technology disruptions leading to new opportunities and remarkable growth potential. Advances in SynBio technologies have transformed drug discovery and therapeutics development, accelerating the identification of novel drug targets and high-throughput compound screening ...
$4,950.00 -
02 May 2023  |  Global  |  Technology Research
Technology Advances in Senolytics
Innovative Drug Development Culture Working to Prolong Health Spans and Eliminate Aging Cells
Senolytics is a relatively new field of development that falls under the broad category of senotherapeutics, along with senomorphics and senostatics. Although nascent, the field could address the root causes of most chronic conditions brought on by aging as it clears senescent cells that have ceased to multiply (and ideally are eliminated from the ...
$4,950.00 -
15 Feb 2022  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential
Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...
$2,450.00 -
11 Jul 2025  |  Global  |  Market Outlook
Global Pharmaceutical Industry Outlook, 2025
Industry Convergence and Technology Adoption Lead to Transformational Growth
In this analysis, Frost & Sullivan identifies and defines the leading trends shaping the global pharmaceutical landscape. The study period is 2022–2030, with 2024 as the base year and 2025–2028 as the forecast period. The geographic scope includes 5 regions: North America, Latin America (LATAM) and the Caribbean, Asia-Pacific (APAC), Europe, and th...
$4,950.00 -
17 Apr 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced Biologic Therapies, AI-powered Diagnostics, Drug Delivery Platforms, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping diagnostics, therapeutics, and clinical workflows across infectious diseases, women’s health, metabolic disorders, neurodegeneration, oncology, rare diseases, and musculoskeletal care. It hi...
$950.00 -
26 Aug 2024  |  Global  |  Market Research
Precision Neurodegenerative Disease Market, Global, 2024 2028
Precision NDD Treatment is Experiencing Transformational Growth due to AI Capabilities, Disease-modifying Therapies, and Industry Convergence
The rising global prevalence of neurodegenerative diseases (NDDs) is driving the shift from symptom-to-disease-modifying therapeutics that target unique pathological mechanisms, such as protein misfolding, neuroinflammation, and synaptic dysfunction, and customizing treatment based on unique genetic profiles, disease subtypes, and distinct biomarke...
$2,450.00